Publications by authors named "M Marotel"

The aim of this study was to evaluate whether community-level monitoring of respiratory and enteric viruses in wastewater can provide a comprehensive picture of local virus circulation. Wastewater samples were collected weekly at the wastewater treatment plant (WWTP) inlet and at the outlet of a nearby nursing home (NH) in Burgundy, France, during the winter period of 2022/2023. We searched for the pepper mild mottle virus as an indicator of fecal content as well as for the main respiratory viruses [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, and respiratory syncytial virus] and enteric viruses (rotavirus, sapovirus, norovirus, astrovirus, and adenovirus).

View Article and Find Full Text PDF
Article Synopsis
  • NK cells often lose their function during tumor development, but the reasons for this are not fully understood.
  • In mouse lymphoma models, the activation of NK cells led to changes resembling T cell exhaustion, including the expression of immune checkpoint proteins, but dysfunction occurred only in the activated NK cell group.
  • Importantly, NK cell dysfunction can be reversed by stopping the stimulation and is positively influenced by interleukin-15, indicating that the dysfunction is a dynamic and reversible process not directly linked to immune checkpoint protein expression.
View Article and Find Full Text PDF

While conventional wisdom initially postulated that PD-L1 serves as the inert ligand for PD-1, an emerging body of literature suggests that PD-L1 has cell-intrinsic functions in immune and cancer cells. In line with these studies, here we show that engagement of PD-L1 via cellular ligands or agonistic antibodies, including those used in the clinic, potently inhibits the type I interferon pathway in cancer cells. Hampered type I interferon responses in PD-L1-expressing cancer cells resulted in enhanced efficacy of oncolytic viruses in vitro and in vivo.

View Article and Find Full Text PDF
Article Synopsis
  • Chemotherapy is the primary treatment for triple-negative breast cancer (TNBC), and there's growing interest in targeting CD73 to enhance immunotherapy effectiveness, as it suppresses anti-cancer immunity.
  • CD73 carries a dual role in promoting tumor survival by both inhibiting immune response and enabling the growth of cancer stem cells (CSCs), which may lead to tumor relapse after treatment.
  • Researchers conducted in silico screening of compounds and found that quercetin and luteolin, when combined with the chemotherapy drug paclitaxel, effectively downregulated pathways associated with CD73 and CSCs, indicating a potential strategy for improved TNBC treatment outcomes.*
View Article and Find Full Text PDF

The large coding potential of vaccinia virus (VV) vectors is a defining feature. However, limited regulatory switches are available to control viral replication as well as timing and dosing of transgene expression in order to facilitate safe and efficacious payload delivery. Herein, we adapt drug-controlled gene switches to enable control of virally encoded transgene expression, including systems controlled by the FDA-approved rapamycin and doxycycline.

View Article and Find Full Text PDF